VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
SPNTSiriusPoint Ltd.
$22.76$2.7B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

SPNT logoSiriusPoint Ltd.(SPNT)Earnings, Financials & Key Ratios

SPNT•NYSE•Insurance & Managed Care
6.2× P/E·Price updated Jun 19, 2026
SectorFinancial ServicesIndustryReinsuranceSub-IndustryProperty and casualty reinsurers
AboutSiriusPoint Ltd. provides multi-line insurance and reinsurance products and services worldwide. The company operates through two segments, Reinsurance, and Insurance & Services. The Reinsurance segment provides coverage to various product lines, which includes aviation and space, casualty, contingency, credit and bond, marine and energy, mortgage, and property to insurance and reinsurance companies, government entities, and other risk bearing vehicles. The Insurance & Services segment offers coverage to various product lines comprising accident and health, environmental, workers' compensation, and other lines of business, including a cross section of property and casualty lines. The company was formerly known as Third Point Reinsurance Ltd. and changed its name to SiriusPoint Ltd. in February 2021. SiriusPoint Ltd. was incorporated in 2011 and is headquartered in Pembroke, Bermuda.Show more
  • Revenue$3.21B+22.6%
  • Combined Ratio83.11%-8.8%
  • Net Income$460M+129.9%
  • Return on Equity20.84%+133.0%
  • Medical Cost Ratio47.41%-34.3%
  • Operating Margin16.89%+89.4%
  • Net Margin14.34%+87.5%
  • ROA3.66%+132.7%
  • Equity / Assets19.66%+27.0%

SPNT Key Insights

SiriusPoint Ltd. (SPNT) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Profitable underwriting: 83.1% combined ratio
  • ✓Strong 5Y profit CAGR of 26.2%
  • ✓Strong Piotroski F-Score: 7/9
  • ✓Low loss ratio of 47.4%
  • ✓Good 3Y average ROE of 15.1%
  • ✓Share count reduced 28.2% through buybacks

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when SPNT posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

SPNT Price & Volume

SiriusPoint Ltd. (SPNT) stock price & volume — 10-year historical chart

Loading chart...

SPNT Growth Metrics

SiriusPoint Ltd. (SPNT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years18.68%
5 Years29.37%
3 Years13.86%
TTM21.83%

Profit CAGR

10 Years-
5 Years26.16%
3 Years-
TTM200.06%

EPS CAGR

10 Years-
5 Years18.99%
3 Years-
TTM319.87%

Return on Capital

10 Years1.83%
5 Years1.68%
3 Years4.53%
Last Year7.83%

SPNT Recent Earnings

SiriusPoint Ltd. (SPNT) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 4/12 qtrs (80%)
Q2 2026Latest
May 7, 2026
Metric
Actual
Est
EPS
$0.82+26.2%
$0.65
Rev
$1.0B+16.9%
$858M
Q1 2026
Feb 18, 2026
Metric
Actual
Est
EPS
$0.70+29.6%
$0.54
Rev
$898M+27.3%
$706M
Q4 2025
Oct 30, 2025
Metric
Actual
Est
EPS
$0.72+41.2%
$0.51
Rev
$754M+33.6%
$564M
Q3 2025
Aug 4, 2025
Metric
Actual
Est
EPS
$0.66+17.9%
$0.56
Rev
$748M+1.2%
$739M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 7, 2026
$0.82vs $0.65+26.2%
$1.0Bvs $858M+16.9%
Q1 2026Feb 18, 2026
$0.70vs $0.54+29.6%
$898Mvs $706M+27.3%
Q4 2025Oct 30, 2025
$0.72vs $0.51+41.2%
$754Mvs $564M+33.6%
Q3 2025Aug 4, 2025
$0.66vs $0.56+17.9%
$748Mvs $739M+1.2%
Based on last 12 quarters of dataView full earnings history →

SPNT Peer Comparison

SiriusPoint Ltd. (SPNT) competitors in Property and casualty reinsurers — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
RNR logoRNRRenaissanceRe Holdings Ltd.Direct Competitor12.91B299.175.289.45%26.93%16.59%0.12
ACGL logoACGLArch Capital Group Ltd.Direct Competitor32.48B91.187.8514.27%22.07%19.02%0.11
GLRE logoGLREGreenlight Capital Re, Ltd.Direct Competitor532.98M16.077.417.47%11.46%11.68%0.01
PFSI logoPFSIPennyMac Financial Services, Inc.Direct Competitor4.3B82.388.86173.81%14.31%12.02%5.35
PLMR logoPLMRPalomar Holdings, Inc.Direct Competitor2.96B111.7015.5858.16%20.15%21.74%0.01
KNTK logoKNTKKinetik Holdings Inc.Direct Competitor3.2B46.5317.6918.98%13.17%10.9%1.32
MKL logoMKLMarkel CorporationProduct Competitor23.11B1847.1610.92-0.96%10.7%9.56%0.23
TRV logoTRVThe Travelers Companies, Inc.Product Competitor66.56B307.8111.225.17%12.88%19.12%0.28

Compare SPNT vs Peers

SiriusPoint Ltd. (SPNT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs RNR

Most directly comparable listed peer for SPNT.

Scale Benchmark

vs MMC

Larger-name benchmark to compare SPNT against a more recognizable public peer.

Peer Set

Compare Top 5

vs RNR, ACGL, GLRE, PFSI

SPNT Income Statement

SiriusPoint Ltd. (SPNT) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Revenue
926.71M377.51M979M884.5M2.22B2.17B2.7B2.61B3.21B3.23B
Revenue Growth %
30.79%-59.26%159.33%-9.65%151.52%-2.39%24.44%-3.28%22.62%21.83%
Medical Costs & Claims
571.64M654.52M699.1M652.4M1.71B2.05B1.85B1.89B1.52B1.76B
Medical Cost Ratio %
61.68%173.38%71.41%73.76%77.06%94.41%68.61%72.13%47.41%54.47%
Gross Profit
355.07M▲ 0%
-277.01M▼ 178.0%
279.9M▲ 201.0%
232.1M▼ 17.1%
510.4M▲ 119.9%
121.3M▼ 76.2%
848.4M▲ 599.4%
728.4M▼ 14.1%
1.69B▲ 131.4%
1.47B▲ 0%
Gross Margin %
38.32%-73.38%28.59%26.24%22.94%5.59%31.39%27.87%52.59%45.53%
Gross Profit Growth %
332.66%-178.01%201.04%-17.08%119.91%-76.23%599.42%-14.14%131.41%-
Operating Expenses
61.33M44.47M78.6M80.2M465.3M544M529.7M495.3M1.14B884.5M
OpEx / Revenue %
6.62%11.78%8.03%9.07%20.92%25.05%19.6%18.95%35.7%27.36%
Depreciation & Amortization
00005.9M8.1M11.1M11.9M1.5M8.2M
Combined Ratio %
68.3%185.16%79.44%82.83%97.97%119.46%88.21%91.08%83.11%81.83%
Operating Income
293.75M▲ 0%
-321.48M▼ 209.4%
201.3M▲ 162.6%
151.9M▼ 24.5%
45.1M▼ 70.3%
-422.7M▼ 1037.3%
318.7M▲ 175.4%
233.1M▼ 26.9%
541.3M▲ 132.2%
587.5M▲ 0%
Operating Margin %
31.7%-85.16%20.56%17.17%2.03%-19.46%11.79%8.92%16.89%18.17%
Operating Income Growth %
752.21%-209.44%162.62%-24.54%-70.31%-1037.25%175.4%-26.86%132.22%-
EBITDA
301.97M-313.25M209.5M160.1M51M-414.6M329.8M245M542.8M615.2M
EBITDA Margin %
32.59%-82.98%21.4%18.1%2.29%-19.09%12.2%9.37%16.94%19.03%
Interest Expense
8.22M8.23M8.2M8.2M34M38.6M64.1M69.6M79.7M78.4M
Non-Operating Income
-8.22M-8.23M-8.2M-8.2M-34M-38.6M-64.1M-69.6M-79.7M-78.3M
Pretax Income
293.75M▲ 0%
-321.48M▼ 209.4%
201.3M▲ 162.6%
151.9M▼ 24.5%
45.1M▼ 70.3%
-422.7M▼ 1037.3%
318.7M▲ 175.4%
233.1M▼ 26.9%
541.3M▲ 132.2%
587.5M▲ 0%
Pretax Margin %
31.7%-85.16%20.56%17.17%2.03%-19.46%11.79%8.92%16.89%18.17%
Income Tax
11.98M-4.01M700K8.1M-10.7M-36.7M-45M30.7M81.2M87.1M
Effective Tax Rate %
4.08%1.25%0.35%5.33%-23.73%8.68%-14.12%13.17%15%14.83%
Net Income
277.8M▲ 0%
-317.69M▼ 214.4%
200.6M▲ 163.1%
143.8M▼ 28.3%
58.1M▼ 59.6%
-386.8M▼ 765.7%
354.8M▲ 191.7%
199.9M▼ 43.7%
459.6M▲ 129.9%
500.2M▲ 0%
Net Margin %
29.98%-84.15%20.49%16.26%2.61%-17.81%13.13%7.65%14.34%15.47%
Net Income Growth %
905.24%-214.36%163.14%-28.32%-59.6%-765.75%191.73%-43.66%129.91%200.06%
EPS (Diluted)
2.64▲ 0%
-3.27▼ 223.9%
2.16▲ 166.1%
1.53▼ 29.2%
0.27▼ 82.4%
-2.51▼ 1029.6%
1.85▲ 173.7%
1.04▼ 43.8%
3.65▲ 251.0%
4.11▲ 0%
EPS Growth %
915.38%-223.86%166.06%-29.17%-82.35%-1029.63%173.71%-43.78%250.96%319.87%
EPS (Basic)
2.71-3.272.181.540.28-2.511.931.063.81-
Diluted Shares Outstanding
105.23M97.05M92.65M92.96M150.16M160.23M169.61M169.47M121.65M121.84M

SPNT Balance Sheet

SiriusPoint Ltd. (SPNT) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Assets
4.67B3.09B3.44B3.54B10.62B11.04B12.87B12.52B12.57B12.48B
Asset Growth %
19.92%-33.94%11.45%2.78%200.36%3.94%16.63%-2.69%0.36%-2.95%
Total Investment Assets
2.96B1.52B989.7M1.16B4.53B8.77B6.08B5.71B5.6B4M
Long-Term Investments
2.96B1.52B125.07M105.3M1.37B5.15B6.08B2.58B2.98B13.39B
Short-Term Investments
00001.08B3.62B2.72B3.12B2.62B4.89B
Total Current Assets
11.76M711.39M008.55B5.26B969.2M08.43B8.37B
Cash & Equivalents
8.2M104.18M639.41M526M999.8M705.3M969.2M682M731.2M1.01B
Receivables
00603.82M552.1M3.2B3.3B4.31B4.42B4.42B15.99B
Other Current Assets
00-1.26B-1.1B3.04B3.62B5.3B-8.69B171.2M0
Goodwill & Intangibles
258.79M203.84M00390.7M163.8M152.7M468.3M505.3M1.68B
Goodwill
00000000018.6M
Intangible Assets
258.79M203.84M00390.7M163.8M152.7M468.3M505.3M139.8M
PP&E (Net)
0000025.9M25.6M000
Other Assets
-258.79M-203.84M-125.07M-105.3M308.7M-5.17B-435.2M9.47B387.3M-5.31B
Total Liabilities
2.9B1.88B2.03B1.97B8.12B8.95B10.34B10.59B10.1B10.18B
Total Debt
113.73M113.91M114.09M114.3M816.7M778M786.2M639.1M688.6M702.9M
Net Debt
105.54M9.73M-525.33M-411.7M-183.1M72.7M-183M-42.9M-42.6M-307.8M
Long-Term Debt
113.73M113.91M114.09M114.3M816.7M778M786.2M639.1M688.6M679.6M
Short-Term Debt
0000000005.1M
Total Current Liabilities
846.45M76.96M004.34B4.89B6.2M5.94B5.32B0
Accounts Payable
846.45M76.96M99.76M95.7M924.6M1.08B2.02B1.8B1.45B0
Deferred Revenue
816.83M0000-18M001.86B0
Other Current Liabilities
-1.66B-79.26M-102.81M-98.78M3.42B3.83B-2.01B4.15B2.01B-5.1M
Deferred Taxes
-1000K-1000K001000K1000K1000K1000K1000K314.5M
Other Liabilities
827.79M0-114.26M-115.3M2.86B3.23B9.45B3.92B4.02B6.81B
Total Equity
1.77B▲ 0%
4.46B▲ 152.2%
1.41B▼ 68.3%
1.57B▲ 10.7%
2.5B▲ 59.9%
2.08B▼ 16.8%
2.53B▲ 21.5%
1.94B▼ 23.4%
2.47B▲ 27.4%
2.3B▲ 0%
Equity Growth %
22.07%152.19%-68.32%10.69%59.92%-16.81%21.51%-23.39%27.44%0.96%
Shareholders Equity
1.66B1.2B1.41B1.56B2.5B2.07B2.51B1.94B2.47B2.3B
Minority Interest
113.63M3.26B01.4M-400K7.9M16.7M1.4M1.1M1M
Retained Earnings
594.02M276.33M476.95M620.4M665M262.2M601M784.9M1.23B1.33B
Common Stock
10.72M9.36M9.42M9.6M16.2M16.2M16.8M11.6M11.7M11.6M
Accumulated OCI
0000-200K-45M3.1M-4.1M61.9M6.3M
Return on Equity (ROE)
17.26%-10.19%6.83%9.65%2.86%-16.87%15.38%8.95%20.84%22.01%
Return on Assets (ROA)
6.49%-8.19%6.15%4.12%0.82%-3.57%2.97%1.57%3.66%4.01%
Equity / Assets
37.88%144.61%41.11%44.28%23.58%18.87%19.66%15.48%19.66%18.45%
Debt / Equity
0.06x0.03x0.08x0.07x0.33x0.37x0.31x0.33x0.28x0.31x
Book Value per Share
16.8245.9915.2616.8416.6713.0014.9211.4420.3118.91
Tangible BV per Share
14.3643.8915.2616.8414.0711.9814.028.6816.1617.61

SPNT Cash Flow Statement

SiriusPoint Ltd. (SPNT) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-78.54M13.39M141.11M73.36M1.6M293.3M581.3M74.7M102.4M326.9M
Operating CF Growth %
-1746.11%117.05%954.1%-48.02%-97.82%18231.25%98.19%-87.15%37.08%438.47%
Operating CF / Revenue %
-8.47%3.55%14.41%8.29%0.07%13.51%21.51%2.86%3.19%10.11%
Net Income
281.77M-317.47M200.62M143.86M55.8M-386M363.7M202.4M460.1M500.2M
Depreciation & Amortization
4.94M4.94M3.96M-4.01M5.9M13.9M11.1M11.9M10.9M5M
Stock-Based Compensation
3.6M4.96M7M6.6M11.4M30.5M21.4M20.7M35.9M0
Deferred Taxes
-8.91M-5.16M-3.96M4.01M0-53.9M-60.2M000
Other Non-Cash Items
-460.5M242.28M-243.96M-255.21M-413.9M393.6M83.1M7.3M-204.6M-208.3M
Working Capital Changes
100.57M83.84M177.45M178.11M342.4M295.2M162.2M-167.6M-199.9M30M
Cash from Investing
23.05M377.56M786.86M6.11M208.6M-1.3B-332.2M343.6M424.2M1.6M
Capital Expenditures
00000-800K0000
Acquisitions
73.98M-97.95M00652.4M800K00224.9M194.8M
Purchase of Investments
-3.89B-4.34B-418.46M-446.96M-3.41B-6.16B-4.97B-2.73B-2.4B-2.17B
Sale/Maturity of Investments
4.28B4.28B1.21B547.97M2.89B4.85B4.63B3.07B2.61B2B
Other Investing
-362.48M432.31M-886K-94.9M77.9M4.5M5.5M6.2M-8.8M-24.5M
Cash from Financing
53.73M-226.94M12.65M-19.48M24.3M-23.7M-61.5M-625M-518.8M-243M
Dividends Paid
-3.22M-3.22M-2.72M-1.29M-12.2M-16M-16M-16M-16M-15.9M
Share Repurchases
-40.86M-138.71M0-300K0-12.1M0-299.7M0-221.9M
Stock Issued
1.5M01.9M050.8M027.8M18.4M-489.9M900K
Debt Issuance (Net)
000001000K-1000K-1000K00
Other Financing
97.82M-84.94M13.47M-17.89M-14.3M-13.2M-55.3M-203.7M-12.9M-6.1M
Net Change in Cash
-1.75M▲ 0%
164M▲ 9450.3%
940.62M▲ 473.5%
59.98M▼ 93.6%
234.5M▲ 291.0%
-1.03B▼ 541.2%
187.6M▲ 118.1%
-206.7M▼ 210.2%
7.8M▲ 103.8%
85.5M▲ 0%
Exchange Rate Effect
0000000000
Cash at Beginning
9.95M549.33M713.34M1.65B1.71B1.95B913.7M1.1B894.6M902.4M
Cash at End
8.2M713.34M1.65B1.71B1.95B913.7M1.1B894.6M902.4M1.01B
Free Cash Flow
-78.54M▲ 0%
13.39M▲ 117.0%
141.11M▲ 954.1%
73.36M▼ 48.0%
1.6M▼ 97.8%
292.5M▲ 18181.3%
581.3M▲ 98.7%
74.7M▼ 87.1%
102.4M▲ 37.1%
326.9M▲ 0%
FCF Growth %
-1746.11%117.05%954.1%-48.02%-97.82%18181.25%98.73%-87.15%37.08%533.55%
FCF Margin %
-8.47%3.55%14.41%8.29%0.07%13.47%21.51%2.86%3.19%10.11%
FCF per Share
-0.750.141.520.790.011.833.430.440.842.68

SPNT Key Ratios

SiriusPoint Ltd. (SPNT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Combined Ratio
68.3%185.16%79.44%82.83%97.97%119.46%88.21%91.08%83.11%81.83%
Medical Cost Ratio
61.68%173.38%71.41%73.76%77.06%94.41%68.61%72.13%47.41%54.47%
Return on Equity (ROE)
17.26%-10.19%6.83%9.65%2.86%-16.87%15.38%8.95%20.84%22.01%
Return on Assets (ROA)
6.49%-8.19%6.15%4.12%0.82%-3.57%2.97%1.57%3.66%4.01%
Equity / Assets
37.88%144.61%41.11%44.28%23.58%18.87%19.66%15.48%19.66%18.45%
Book Value / Share
16.8245.9915.2616.8416.671314.9211.4420.3118.91
Debt / Equity
0.06x0.03x0.08x0.07x0.33x0.37x0.31x0.33x0.28x0.31x
Revenue Growth
30.79%-59.26%159.33%-9.65%151.52%-2.39%24.44%-3.28%22.62%21.83%
Related:SPNT Dividend History·SPNT Revenue History·SPNT Price History·SPNT P/E History·SPNT Financial Ratios·SPNT Institutional Holders

SPNT SEC Filings & Documents

SiriusPoint Ltd. (SPNT) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 7, 2026·SEC

Material company update

Mar 30, 2026·SEC

Material company update

Mar 23, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 24, 2026·SEC

FY 2025

Feb 21, 2025·SEC

FY 2024

Feb 29, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 7, 2026·SEC

FY 2025

Oct 30, 2025·SEC

FY 2025

Aug 4, 2025·SEC

SPNT Frequently Asked Questions

SiriusPoint Ltd. (SPNT) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

SiriusPoint Ltd. (SPNT) grew revenue by 22.6% over the past year. This is strong growth.

Yes, SiriusPoint Ltd. (SPNT) is profitable, generating $500.2M in net income for fiscal year 2025 (14.3% net margin).

Dividend & Returns

Yes, SiriusPoint Ltd. (SPNT) pays a dividend with a yield of 0.58%. This makes it attractive for income-focused investors.

SiriusPoint Ltd. (SPNT) has a return on equity (ROE) of 20.8%. This is excellent, indicating efficient use of shareholder capital.

Industry Metrics

SiriusPoint Ltd. (SPNT) has a combined ratio of 83.1%. A ratio below 100% indicates underwriting profitability.

What if you invested $1,000 in SPNT back in 2011?

Total return calculator · dividends reinvested · 15+ years of data

See returns →

How much would $100/month in SPNT be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →